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Abstract
Background: Aerobic exercise and cognitive training have been effective in improving cognitive functions; however,
whether the combination of these two can further enhance cognition and clinical outcomes in stroke survivors with
cognitive decline remains unknown. This study aimed to determine the treatment effects of a sequential combination
of aerobic exercise and cognitive training on cognitive function and clinical outcomes.
Methods/design: Stroke survivors (n = 75) with cognitive decline will be recruited and randomly assigned to cognitive
training, aerobic exercise, and sequential combination of aerobic exercise and cognitive training groups. All participants
will receive training for 60 minutes per day, 3 days per week for 12 weeks. The aerobic exercise group will receive
stationary bicycle training, the cognitive training group will receive cognitive-based training, and the sequential group
will first receive 30 minutes of aerobic exercise, followed by 30 minutes of cognitive training. The outcome measures
involve cognitive functions, physiological biomarkers, daily function and quality of life, physical functions, and social
participation. Participants will be assessed before and immediately after the interventions, and 6 months after
the interventions. Repeated measures of analysis of variance will be used to evaluate the changes in outcome
measures at the three assessments.
Discussion: This trial aims to explore the benefits of innovative intervention approaches to improve the cognitive
function, physiological markers, daily function, and quality of life in stroke survivors with cognitive decline. The findings
will provide evidence to advance post-stroke cognitive rehabilitation.
Trial registration: ClinicalTrials.gov, NCT02550990. Registered on 6 September 2015.
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Background
Post-stroke cognitive impairment is a major problem
that affects up to 70% of stroke survivors [1–3]. Persist-
ent cognitive impairment after stroke not only causes
deterioration in patients’ ability to relearn motor skills
due to memory problems or poor judgment, but also
significantly impairs the activities of daily living (ADL)
and quality of life (QOL) [4].
Post-stroke cognitive impairment and rehabilitation
have recently been identified as the top research priority
for post-stroke survivors [5]. Current evidence indicates
that targeted cognitive rehabilitation after stroke, includ-
ing exercise training [6–8] or cognitive training [9, 10],
provides potential means of promoting cognitive func-
tion. A recent overview of the evidence for the effective-
ness of cognitive rehabilitation for stroke survivors
suggests that cognitive training targeting specific cogni-
tive domains has some positive effects [11]. For example,
Starovasnik Žagavec et al. [12] studied the effect of
computer-based cognitive rehabilitation on work-active
patients after stroke and reported a moderate to strong
effect on the divided attention and a mild effect on the
alertness. They suggested that the attention system can
be rehabilitated by training the reaction speed and learn-
ing the awareness and selection of suitable stimuli.
Another randomized controlled trial examined the effects
of 5 weeks working memory training in stroke survivors
and found training effects on attention and subjective ex-
perience of cognitive functioning in daily living (as mea-
sured by the Cognitive Failure Questionnaire) [13]. These
results provide evidence that intensive cognitive training
can improve cognitive function in stroke survivors. A re-
cent study suggests that the increased resting-state func-
tional connectivity of the hippocampus with the frontal
and parietal lobes may be an important mechanism of
cognitive recovery after stroke [14].
Another important approach that has been proposed
to enhance cognitive function is aerobic exercise. In
addition to the well-known benefits of exercise in im-
proving physical function and reducing the risk of sec-
ondary complications, exercise has been found to lower
the risk of developing Alzheimer’s disease and related
cognitive disorders [15]. Cumming and colleagues con-
ducted a systematic review and reported that increased
physical activity after stroke improves cognitive func-
tions [16]. It has been suggested that aerobic exercise
may increase the arousal level and reduce depressive
symptoms, which in turn leads to better cognitive function
[16]. The improvement in cognitive function after exercise
could be induced by the upregulation of neurotrophic and
vascular growth factors, which may facilitate neurogenesis,
angiogenesis, and synaptic plasticity of the hippocampus
and other cognition-related cortical areas [17, 18]. It has
been shown that the neurotrophin brain-derived
neurotrophic factor (BDNF) plays a role in regulating syn-
aptic connectivity [19]. Recently, several clinical studies
have demonstrated that BDNF may be act as a biomarker
of memory and general cognitive function in healthy
adults [20], and in patients with schizophrenia [21]
and Parkinson’s disease [22]. Although BDNF has
been widely investigated, the mechanism of action
and the biological correlates of cognitive rehabilitation in
patients with stroke are still unknown. Also, it remains
unclear whether BDNF serum levels may be used as a bio-
marker of cognitive training in patients with stroke.
Current evidence is insufficient to establish clinical
practice recommendations due to the small sample sizes,
unclear treatment details and different measurements of
the outcome variable. There is urgent need to perform a
high-quality randomized controlled trial (RCT) that is
adequately powered, using the optimum intervention
and validated outcome measurements. Furthermore, few
of the prior studies included outcome measures of
changes in physiological markers, ADLs, and QOL.
Growing evidence suggests that a hybrid combination of
aerobic exercise and cognitive training may provide add-
itional benefits in cognitive performance that go beyond
the effects of a single type of training in animals [23],
community-dwelling elderly [24, 25], and stroke survi-
vors [26]. A systematic review of combining exercise and
cognitive intervention in older adults suggests that exer-
cise sessions delivered before the cognitive training
session prepares the brain for the compensatory recruit-
ment process in the subsequent cognitive training ses-
sions [25]. Aerobic exercise before cognitive training
may increase arousal level, facilitate neurogenesis and
enhance memory consolidation, which may benefit the
memory retrieval and cognitive task performance that
follows [27, 28]. Aerobic exercise training combined
with cognitive training might be a plausible interven-
tion to augment cognitive function and intensify re-
habilitation outcomes.
We are conducting a single-blind, adequately powered,
high-quality RCT to test the hypothesis that a sequential
combination of aerobic exercise and cognitive training
will promote cognitive performance in stroke survivors
with cognitive impairment. Specifically, we aim to deter-
mine the treatment effects of the hybrid training, com-
pared with exercise or cognitive training alone, on: (1)
cognitive function and (2) physiological markers, daily
function, quality of life, physical function, and social
participation.
Methods/design
Study design and setting
This study will be a single-blind, multisite, randomized
controlled trial. After signing the informed consent, par-
ticipants will be stratified by Mini-Mental State
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Examination (MMSE) scores and randomly assigned to
the cognitive training (COG), aerobic exercise (AE), or
sequential combination of aerobic exercise and cognitive
training (SEQ) groups (Fig. 1) by an independent research
assistant. The randomization scheme will be generated with
the web-based randomization tool (available at http://
www.randomizer.org/), applying block randomization to
achieve three groups with a ratio of 1:1:1. All participants
will receive 36 training sessions over a 3-month period.
The participants will be assessed before and immediately
after the intervention programs, and 6 months after the
intervention programs. The evaluator for all assess-
ments (before, after, and follow up) will be blinded to
the group allocation. Figure 2 illustrates the timing of
all trial processes (Additional file 1).
Sample size
No published research to date has investigated the
effects of combining aerobic exercise with cognitive
training on cognitive functions in patients with stroke;
therefore, the sample size calculation was based on the
effects of a similar study conducted by Kim et al. [29].
The study investigated the effects of 4 weeks of cogni-
tive, combined, motor dual-task training on cognitive
and motor function in stroke survivors. The Stroop test,
Timed Up and Go (TUG) test, 10-Meter Walk Test
(10MWT), Figure-of-8 Walk Test (F8WT) and gait
speed were used to measure cognitive and motor abil-
ities and were evaluated three times (before and after
training and at the 2-week follow up). The results
showed that compared to the single-task training, the
active control group, dual-task training improves cogni-
tive and motor functions in stroke survivors, and these
training benefits were maintained for 2 weeks.
A priori power analysis (G*Power software 3.1) was
used to estimate the number of participants needed for
this project. On the basis of Kim’s work [29], the esti-
mated sample size requirement is 20 patients for each
group in a three-group study design given the lowest
effect size (f = 0.30), power of 0.80, and two-sided type I
error of 0.05. Allowing for 20% attrition at the 6-month
follow up, we plan to recruit 25 participants for each
group, resulting in a sample size of 75 participants.
Participant recruitment
This proposed study will be conducted in the outpatient
units of the Departments of Neurology and Rehabilita-
tion in Chang Gung Memorial Hospitals at five branches
(Taoyuan, Chiayi, Kaohsiung, Keelung and Taipei) in
Taiwan. This trial was approved by the centralized ethics
committee of Chang Gung Memorial Hospital Human
Research Ethics Board (Institutional Review Board
(IRB)# 104-4892A3). Participants will be recruited via
the clinic database according to diagnosis and medical
referral; interested participants will meet with the
study personnel to receive all necessary information.
The participants will resolve any uncertainties and be
invited to sign informed consent after an assessment
of eligibility criteria.
Inclusion and exclusion criteria
Participants eligible for the study must comply with all
of the following criteria before randomization: (1) unilat-
eral ischemic or hemorrhagic stroke occurring at least
6 months before enrolment; (2) age between 20 and
90 years [30]; (3) MMSE score ≥ 19; (4) Montreal
Cognitive Assessment (MoCA) < 26; (5) self-reported or
informant-reported memory or cognitive complaints or
Clinical Dementia Rating Scale (CDR) score ≤ 0.5; (6)
able to follow the study instruction; (7) adequate cardio-
pulmonary function to perform aerobic exercise; and (8)
able to walk with or without assistive devices. Patients
who have one or more of the following criteria will be
excluded from the study: (1) unstable medical history (e.g.,
recent myocardial infarction) that might limit participa-
tion; (2) other neurologic disorders (e.g., Parkinson’s dis-
ease, amyotrophic lateral sclerosis, multiple sclerosis); and
(3) current participation in another interventional trial.
Interventions
Participants will be randomized to the COG, AE, or
SEQ groups. The experimental intervention will be
added to the existing conventional neurorehabilitative
treatment as prescribed by each clinic. Conventional
treatment, including physiotherapy and occupational
Fig. 1 Flow diagram of the study
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therapy, will be documented. The total conventional
treatment time will be an hour for all participants across
all investigational sites to ensure the amount of conven-
tional neurorehabilitative treatment time is consistent. A
licensed occupational therapist will train the interven-
tionists to ensure standardized treatment delivery. After
the initial training, the occupational therapist will test
the interventionists to determine whether they are cap-
able of conducting the standardized intervention proto-
col. Periodic on-site supervision will be administered to
prevent protocol deviations. The interventionists will
use standardized protocol calendars to record the treat-
ment dosage and participants’ progress and responses
during each intervention session. The standardized
protocol calendars will be reviewed by the principle in-
vestigator to ensure adequate “dose” of treatment is
received and consistent dose of treatment across sites.
Cognitive training (COG)
Computer-assisted cognitive training (i.e., the BrainHQ
program) will be used to facilitate several cognitive func-
tions in the COG group. The specific domains of cogni-
tive function to be targeted are attention, recognition,
color and shape identification, calculation, visual percep-
tion, visuospatial processing, and executive function.
Computer-assisted cognitive training allows automation
of many cognitive training procedures, making it pos-
sible to improve stimulation quality, increase patient rec-
ord reliability, and optimize performance. Participants
will perform a variety of tasks designed to enhance dif-
ferent types of cognitive functions. The training program
will be adjusted automatically and continuously accord-
ing to each participant’s level of performance. Each cog-
nitive intervention session will last 60 minutes.
Aerobic exercise training (AE)
The AE group will perform progressive resistive station-
ary bicycle training as in Quaney et al. [8]. The partici-
pants will first perform 10 minutes of warm up, followed
by 45 minutes of resistive aerobic exercise and 5 minutes
of cool down. The target heart rate during the aerobic
period will be 40–70% of the patient’s maximal heart
rate, calculated as (208 − 0.7 × age) [31]. The exercise in-
tensity will be progressed as the participants improve
their performance throughout practice. Vital signs and
the Borg Perceived Exertion Scale [32] will be monitored
and recorded during each exercise session. The mean
heart rate will be recorded. Each aerobic exercise session
will last for 60 minutes.
Sequential combination of aerobic exercise and cognitive
training (SEQ)
Participants in the SEQ group will receive aerobic exer-
cise training and computer-assisted cognitive training
combined. Each session will contain 30 minutes of the
aerobic exercise, followed by 30 minutes of cognitive
training. The participants will first perform 3 minutes of
warm up, followed by 25 minutes of aerobic resistive ex-
ercise, and end with 2 minutes of cool down for a total
of 30 minutes of exercise training. The aerobic exercise
intensity will be similar to the AE group. Vital signs,
Borg Perceived Exertion Scale [32], and mean heart rate
will be monitored and recorded. After the aerobic exer-
cise, the participants will take part in 30 minutes of cog-
nitive training similar to the training paradigm used in
the COG group.
Outcome assessment
Outcomes will be measured once before the interven-
tion, at 12 weeks after the intervention, and at 6 months
after the intervention, with each assessment lasting 1 to
1.5 hours. Assessments will be conducted by a trained
and experienced therapist who is blinded to group allo-
cation. None of the assessors will participate in the
training intervention.
Some standardized measures will be used to assess
changes. At baseline, additional assessments of disease
severity of the participants will be administered for
classification of the included patients, including the
National Institutes of Health Stroke Scale (NIHSS),
Fugl-Meyer Assessment (FMA), Modified Rankin Scale
(MRS), and MMSE.
Primary outcome measure: cognitive functions
The Montreal Cognitive Assessment (MoCA) is a 30-
point test that examines general cognitive functions, in-
cluding memory, attention, language, visuospatial ability
and execution, naming, delayed recall, abstraction, and
orientation. The MoCA is a feasible tool to evaluate the
global cognitive function in a large population of pa-
tients with stroke [33]. Good-to-excellent reliability and
validity have been established in patients with cerebro-
vascular disease [34].
The Wechsler Memory Scale – Third Edition (WMS–III),
a standardized and reliable neuropsychological tool, is de-
signed to evaluate visuospatial and memory functions [35].
The Faces Recognition, Verbal Paired Associates, Word
Lists, and Spatial Span WMS–III subtests will be used to as-
sess the immediate, delayed, and working memory [36]. For
the Faces Recognition test, the participant will be required
to look through all of the faces and recognize those faces
later. For the Verbal Paired Associates test, the participant
will be instructed to memorize several pairs of words and
then will be asked to respond to the appropriate word that
matches the test word. In the Word Lists test, the instructor
will read out a list of words, and the participants will be
instructed to repeat as many words as they can immediately
and 30 minutes afterwards. During the Spatial Span test, the
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instructor will point to spatially located blocks in a sequen-
tial order; the participants will be instructed to touch the
blocks in the same sequential order or a reversed order.
The Wechsler Adult Intelligence Scale – Third Edition
(WAIS–III) is a widely used and accepted assessment
tool for verbal comprehension, working memory, per-
ceptual organization, and processing speed [37], with
high reliability and validity, and is often used to differen-
tiate individuals with cognitive deficits from those with
intact cognitive functions. We will use the Digit Symbol-
Coding and Matrix Reasoning tests. The Digit Symbol-
Coding test consists of 9 digit-symbol pairs, and the
participants will be asked to write the corresponding
symbols for the given digits on the test sheet as accur-
ately and as fast as possible. The Matrix Reasoning test
requires the participants to solve missing puzzles within
given matrixes, which entail the abilities of visual-spatial
reasoning, abstract reasoning, visual organization, and
visuospatial information processing [36].
The Useful Field of View (UFOV) is a computer-based
visual test that assesses visuomotor processing speed,
divided attention, and selective attention. The UFOV is
the visual area over which information can be extracted
from a brief glance without eye or head movements. The
UFOV has good test-retest reliability and validity to as-
sess patients with stroke [38].
The Stroop Color-Word test assesses the abilities of
selective attention, inhibition, and executive function.
The participants will be tested under congruent and in-
congruent conditions. In the congruent condition, the
participant will name the color of the ink of a word,
which is consistent with the written color name;
whereas, in the incongruent condition, the participant
will name the color of the ink, which differs from the
written color name. In both conditions, the number of
colors correctly named within 45 seconds will be mea-
sured, and the performance in the congruent condition
will be compared with the incongruent condition.
The dual-task test evaluates the ability to shift atten-
tion between one task and another. Participants will per-
form the Box and Block test (BBT) while doing
secondary cognitive tasks while sitting. Participants will
perform the BBT using the affected and less affected
hand. Two cognitive secondary tasks will be performed:
(1) arithmetic task: participants will be asked to perform
serial subtractions by 3 starting from 100 or random
two-digit numbers (e.g., as previously described [39]); (2)
tone discrimination task: participants will be presented a
number of low-pitched and high-pitched tones and will
calculate and remember the number of high-pitched
tones during the trial. Both cognitive task performances
will be recorded and the results compared against a sin-
gle cognitive task performance. Participants will perform
both secondary cognitive tasks while walking.
Secondary outcomes
Physiological markers
The cognitive and physical related biomarkers will be
collected at baseline and immediately after the interven-
tion programs. In particular, the level of BDNF will be a
biomarker after cognitive rehabilitation, whereas the an-
tioxidative marker, blood glucose indicator, and plasma
lipid levels will be evaluated as exercise-related factors.
For the assessment of BDNF, blood (8 mL) will be col-
lected in sampling tubes and centrifuged at 2000 g for
20 minutes. Serum will be harvested, aliquoted, and
stored at – 80 °C until analysis. The automated ferric-
reducing ability of plasma assay will be implemented to
measure the antioxidative marker. Serum BDNF will be
quantified using an enzyme-linked immunosorbent assay
(Human BDNF Quantikine Immunoassay, DBD00, R&D
Systems) according to the manufacturer’s instructions.
This sandwich enzyme-linked immunosorbent assay is set
to measure natural and recombinant human mature
BDNF in serum and plasma. All assays will be performed
on F-bottom 96-well plates (Nunc, Wiesbaden, Germany).
Antioxidative markers will be used to reflect the changes
in oxidative stress. In particular, we will be analyzing the
total antioxidant capacity. HbA1c level will be tested to in-
vestigate the relationships between blood glucose level
and aerobic exercise. Last, the cholesterol ratio (total chol-
esterol/high-density lipoprotein cholesterol) will be evalu-
ated to reflect the lipid level in the blood.
ADLs and QOL
The Functional Independence Measure (FIM) and
Lawton Instrumental Activities of Daily Living Scale
(Lawton IADL) will be used to evaluate ADLs. The FIM
assesses the dependence level of individuals with stroke
to perform 18 ADLs. The score ranges from 18 to 126,
and higher scores demonstrate greater independent par-
ticipation in daily activities [40]. The FIM has good
inter-rater reliability and validity [41].
The Lawton IADL assesses independent living skills
such as shopping or managing finances [42]. The ability
to perform IADLs has often been shown to decline be-
fore basic ADLs; hence, evaluating IADLs may help cli-
nicians to identify early deterioration in physical and/or
cognitive functions. The Lawton IADL scale evaluates
eight activities with a score range from 0 to 8 (a higher
score indicates better function).
QOL will be assessed with the Stroke Impact Scale
(SIS) 3.0, EuroQoL (EQ)-5D, and Caregiver Burden (CB)
scale. The SIS 3.0, which will be used to evaluate health-
related QOL in the patients with stroke, uses 59 test
items to assess 8 domains (strength, hand function,
ADL/IADL, mobility, communication, emotion, memory
and thinking, and participation/role function). Participants
rate each item according to their perceived difficulty to
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accomplish the task during the past week. The psycho-
metric properties of SIS in individuals with chronic stroke
have been well-established [43].
The CB scale evaluates the burden of the primary
caregiver of the participants. Lessening the burden of
caregivers after the intervention may significantly im-
prove the QOL for patients with stroke and their fam-
ilies. The CB scale measures factors related to general
strain, isolation, disappointment, emotional involvement,
and environment of the caregivers. The CB scale for
caregivers of stroke patients has moderate-to-good test-
retest reliability and construct validity [44].
QOL will be assessed by the EQ-5D questionnaire,
which comprises the 5 dimensions of mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression.
Each dimension has 3 levels: no problems, some prob-
lems, extreme problems. The score has been shown to
be reliable and valid [45].
Physical function
Objective outcomes will include physical domains in bal-
ance, lower extremity muscle endurance and strength,
mobility level, a subjective measure to assess changes in
health-related physical activity, and motor impairment
level. The TUG test assesses dynamic balance ability and
mobility. The participants will be required to stand up
from a chair, walk 3 m, turn around, walk back to the
chair, and sit down. The time to complete the TUG test
has been shown to be a good indicator to detect po-
tential fallers in frail elderly individuals [46]. The test-
retest reliability of TUG in individuals with stroke
was excellent [47].
The 6-Minute Walk Test (6MWT) measures the max-
imum distance walked over 6 minutes, which assess the
endurance and mobility level of the participants. The
participants can rest as needed during the test. The test-
retest reliability and responsiveness have been estab-
lished to be high for patients with chronic stroke [48].
Accelerometers will be used to provide an objective
measure of the amount of arm movements in real-life
situations (i.e., the mobility level). The participants will be
asked to wear an Actigraphy activity monitor (ActiGraph,
Shalimar, FL, USA) on both wrists for 3 consecutive days
before and after training to measure the number of moves
each minute and the average counts of move per minute.
The participants will be required to wear the device dur-
ing the day except for doing water-based activities such as
bathing or swimming. Data recorded by the Actigraphy
will be analyzed with the MAHUFFE software (http://
www.mrc-epid.cam.ac.uk/). The use of the Actigraphy to
measure arm use and physical activity has been estab-
lished in patients with stroke [49].
The International Physical Activity Questionnaires
(IPAQ) is an international measure of health-related
physical activity. The short-form version of the Chinese
IPAQ will be used to assess changes in physical activ-
ity before and after the intervention. The reliability
and validity of IPAQ have been established in 12
countries [50, 51].
The 33-item upper limb subscale of the FMA will be
used to assess motor impairments. Items are scored on a
3-point ordinal scale (0 = cannot perform, 1 = performs
partially, 2 = performs fully), with a total of score of 66.
Proximal shoulder/elbow and distal hand/wrist sub-
scores will be calculated. The reliability, validity, and re-
sponsiveness of the FMA, and the clinically important
differences when using the FMA have been well-
established in stroke patients [52, 53].
The Rivermead Mobility Index (RMI) evaluates the
participant’s bed mobility, postural transfers, and walk-
ing ability. It contains a 15-item scale that includes 14
questions and 1 direct observation, with a total of score
of 15. The RMI has been shown to have excellent correl-
ation with the Functional Independence Measure (FIM)
and the Barthel Index [54].
Finally, we will evaluate lower extremity muscle
strength (e.g., isometric knee flexors and extensor
muscle strength) and the grip strength of the affected
and less affected hand using a handheld dynamometer.
During the lower extremity examination, the participant
will be seated upright in a chair with back support and
the knee will be placed in 90° flexion. The evaluator will
stabilize the participant to eliminate synergistic move-
ments. Participants will be asked to perform a maximal
isometric contraction of knee flexion and extension with
the affected and less affected side. The hand dynamom-
eter will also measure grip strength while the participant
is seated with the elbow at 90° flexion. We will record
the mean value of three attempts of upper and lower ex-
tremity assessments.
Social participation and level of depression
The participant’s level of social participation will be
assessed using the Community Integration Question-
naire (CIQ). The CIQ measures 15 items relevant to
home integration, social integration, and productive ac-
tivities [55]. The total score ranges from 0 to 29 points.
The CIQ has been tested on various populations
with acquired brain injuries, and test-retest reliability
was excellent for chronic stroke patients with apha-
sia [55, 56]. The Geriatric Depression Scale (GDS) is
a self-administered questionnaire used to evaluate
mood and depressive symptoms, with each question
requiring a yes or no response. A short form of the
GDS will be used in this study to assess the partici-
pants. The reliability, internal consistency, and valid-
ity have been established to be good to excellent in
patients with stroke [57].
Yeh et al. Trials  (2017) 18:405 Page 7 of 11
Analyses
We will use the chi square (χ2) test and analysis of vari-
ance to analyze differences in baseline characteristics
and baseline outcome measures among the groups.
Mixed-factor repeated-measures analysis of variance will
be used to determine the intervention effect in the three
groups. The within-subject factor will be time (pretest,
posttest, and follow up), and the between-subjects factor
will be group (COG, AE, and SEQ). Tukey’s test will be
performed if a group × time interaction or a main effect
is observed. Statistical significance will be set at 0.05 for
all comparisons. In addition to p values, η2 will also
be calculated to determine the group difference for
each outcome measure. Data analysis will be per-
formed using PASW Statistics 18.0 software (SPSS
Inc., Chicago, IL, USA).
Data management and quality
A paper-based assessment form will be used by inde-
pendent outcome evaluators to record the outcome
measures. A trained research assistant who is independ-
ent of the trial will manually enter the data into an elec-
tronic database; another independent research assistant
will check data quality and accuracy (e.g., range checks,
checking for missing data for required data points). The
data collection sheets and signed informed consent
forms will be stored in a locked cabinet, and the elec-
tronic database will be password-protected. Blood
samples will be collected by nurse practitioners from
a peripheral vein in the patient’s forearm. A standard
operating procedure (SOP) for blood sample collec-
tion, handling, and storage will be established to en-
sure data stability.
Adverse event monitoring and reporting
Adverse events will be carefully monitored during the
trial. Expected serious events include recurrent stroke or
transient ischemic attack (TIA), myocardial infarction,
fracture, pulmonary embolism, and death. Expected
non-serious events include falls, severe pain or muscle
soreness, excessive blood pressure responses, and dizzi-
ness. The interventionists will closely monitor the partic-
ipants, especially during the aerobic exercise training to
minimize the risk of any adverse event. Adverse events
will be reported immediately to the responsible phys-
ician and the principle investigator, and will then be re-
ported to the IRB in accordance with the procedures of
Chang Gung University, Taoyuan, Taiwan.
Discussion
Advances in stroke management, including intravenous
thrombolysis, endovascular therapy with thrombectomy,
organized care for ischemic stroke, and extensive control
of risk factors for stroke prevention, have resulted in a
gradual decrease in the mortality rate and an increase in
life expectancy after stroke. The management of neuro-
logic deficits and declined function after stroke has
become a critical issue. In contrast to the successful
pharmaceutical management of risk factors and great
emphasis on motor function recovery, interventions for
cognitive impairment remain under development.
Cognitive deficits after stroke are strongly associated
with functional disability, institutionalization rate, and
the risk of developing dementia. Treatment to reserve
cognitive ability is emerging, and attention in recent de-
cades has shifted toward this less visible cognitive im-
pairment. There is no consensus about pharmacologic
interventions [58], and the use of medicines alone for
cognitive decline after stroke is not highly recom-
mended. Accordingly, structuring non-pharmacologic
interventions to increase or reserve patients’ cognitive
capacity is important.
Aerobic exercise is considered to be effective in im-
proving cognitive function and has the advantages of be-
ing simple, convenient, efficient, inexpensive, and
without severe adverse effects [59]. Targeted cognitive
training after stroke has also been shown to promote
cognition [9]. The recent use of combined therapy has
increasingly attracted attention. Aerobic exercise com-
bined with cognitive training, which has not been
studied in patients with stroke, might offer a new break-
through in training cognitive function after stroke. A
systematic review has proposed that despite the increase
in the number of studies that have focused on training
for cognitive function after stroke, the lack of high-
quality research has prevented the development of
evidence-based recommendations for clinical practice
[11]. The review also recommends that the optimal
intervention approach should use a large sample, an ad-
equate dose of treatment, and explore changes in
physiological markers, ADLs, and QOL after training.
The long-term retention of the training benefits should
also be assessed. This trial represents endeavor toward
this possibility.
The objectives of this proposed trial are to determine
the treatment effects of a sequential combination of aer-
obic exercise and cognitive training, compared with ex-
ercise or cognitive training alone, on cognitive function,
physiological markers, daily function, QOL, physical
function, and social participation. A notable difference
between our study and previous studies is that this trial
will investigate the physiological biomarkers and a var-
iety of outcomes related to patient’s ADL, QOL, and so-
cial participation. The serum BDNF level has been
selected to evaluate whether cognitive training can up-
regulate the neurotrophic and vascular growth factors,
and the relationship between cognitive performance and
serum BDNF levels will be assessed.
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Meanwhile, because the fundamental goal of rehabili-
tation is to improve everyday functioning, determining
the effect of cognitive training on ADL, QOL, and social
participation is important. The establishment of a core
set of outcome measures would be particularly helpful
because these outcomes reflect the “real-life” significance
of cognitive training. The trial also aims to determine
the long-term treatment effects of different training
protocols on these outcome measures. A 12-week
intervention and a 24-week follow-up assessment can
potentially provide reliable evidence on the long-term
effects of the therapeutic regimen of cognitive train-
ing in stroke survivors.
Limitations of the design and implementation of the
trial must also be considered. In this trial, we designed
the cognitive training and aerobic exercise training
groups as comparisons to a sequential combination of
aerobic exercise and cognitive training rather than in-
cluding a passive control group. Our primary aim in this
trial is a parallel comparison of three experimental inter-
ventions rather than a comparison with conventional
therapy. Hence, no control group that receives trad-
itional cognitive training will be included.
With the global population aging and the increasing
number of stroke survivors, there is growing urgency to
identify the most effective methods to promote cognitive
function. We believe that the information garnered from
this trial will provide evidence for the potential synergis-
tic intervention on cognitive function in stroke survi-
vors, which is crucial to health care professionals
involved in cognitive rehabilitation.
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